Advanced search
Publication Cover
Expert Opinion on Orphan Drugs Volume 8, 2020 - Issue 9: Special issue on Rare Cancers
Submit an article Journal homepage
1,250
Views
0
CrossRef citations to date
0
Altmetric
Foreword

Rare cancers, the continued agenda for progress – editor’s special foreword

Daniel J O’ConnorExpert Medical Assessor, Medicines and Healthcare Products Regulatory Agency (MHRA), London, UKCorrespondence[email protected]
View further author information
Pages 309-310 | Published online: 22 Sep 2020

References

  • O’Connor DJ. Editors foreword: evolving the rare cancer field. Expert Opin Orphan Drugs. 2018;6(9):507–508.
  • Rare Cancer Agenda 2030. Ten recommendations from the EU joint action on rare cancers. [ cited August 16 2020]. https://ecpc.org/wp-content/uploads/2020/02/ecpc-jarc-rare-cancer-agenda_2030-ten-recommendations-from-the-EU-Joint-Action-on-Rare-Cancers-2.pdf
  • Bagante F, Tripepi M, Spolverato G, et al. Assessing prognosis in cholangiocarcinoma: a review of promising genetic markers and imaging approaches. Expert Opin Orphan Drugs. 2020:8(9). DOI: 10.1080/21678707.2020.1801410
  • Najjar O, Erickson BK, Nickles-Fader ADiagnosis and management of uterine serous carcinoma: current strategies and clinical challenges. 2020:8(9). DOI: 10.1080/21678707.2020.1784723
  • Weiss M, Agulnik M. Tazemetostat as a treatment for epithelioid sarcoma. 2020:8(9). DOI: 10.1080/21678707.2020.1809377
  • Moia R, Patriarca A, Mahmoud AM, et al. Assessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics. 2020:8(9). DOI: 10.1080/21678707.2020.1804860
  • Marini F, Giusti F, Tonelli F, et al. Multiple endocrine neoplasia type 1: a review of current diagnostic and treatment approaches. 2020:8(9). DOI: 10.1080/21678707.2020.1811086
  • Morimoto A, Kudo K.Hematopoietic stem cell transplantation for Langerhans cell histiocytosis: clinical findings and long-term outcomes. 2020:8(9). DOI: 10.1080/21678707.2020.1778462

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.